4
Changes in Ownership
Raphael Pharmaceutical Inc. Filed Acc 0001213900-23-019554
Options or other derivatives
- Chief Technology Officer acquired 999,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Louria Hayon Igal Chief Technology Officer | 2022-12-05 | Grant or award · Warrants to Purchase Common Stock | +999,000 | 990,000 | D | ||
Loading xslF345X03/ownership.xml…